BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10725102)

  • 1. Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical.
    Mathias CJ; Hubers D; Low PS; Green MA
    Bioconjug Chem; 2000; 11(2):253-7. PubMed ID: 10725102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
    Trump DP; Mathias CJ; Yang Z; Low PS; Marmion M; Green MA
    Nucl Med Biol; 2002 Jul; 29(5):569-73. PubMed ID: 12088727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological assessment of folate-accepted developer (99m)Tc-DTPA-folate-polymer.
    Chen F; Shao K; Zhu B; Jiang M
    Bioorg Med Chem Lett; 2016 May; 26(10):2547-2550. PubMed ID: 27072904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
    Mishra G; Hazari PP; Kumar N; Mishra AK
    J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical.
    Mathias CJ; Wang S; Waters DJ; Turek JJ; Low PS; Green MA
    J Nucl Med; 1998 Sep; 39(9):1579-85. PubMed ID: 9744347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of diethylenetriamine pentaacetic acid-polyethylene glycol-folate: a new folate-derived, (99m)Tc-based radiopharmaceutical.
    Liu M; Xu W; Xu LJ; Zhong GR; Chen SL; Lu WY
    Bioconjug Chem; 2005; 16(5):1126-32. PubMed ID: 16173789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and Evaluation of Novel Folate Isonitrile
    Feng J; Zhang X; Ruan Q; Jiang Y; Zhang J
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-PEG-CKK(2)-DTPA, A Potential Carrier for Lymph-Metastasized Tumor Targeting.
    Gu B; Xie C; Zhu J; He W; Lu W
    Pharm Res; 2010 May; 27(5):933-42. PubMed ID: 20221899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.
    Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK
    Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of receptor-based tumor imaging agent: (99m)Tc-folate-glucaric acid.
    Onursal M; Lambrecht FY; Ozgur A
    Int J Pharm; 2011 Sep; 416(1):288-92. PubMed ID: 21782912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
    Leamon CP; Parker MA; Vlahov IR; Xu LC; Reddy JA; Vetzel M; Douglas N
    Bioconjug Chem; 2002; 13(6):1200-10. PubMed ID: 12440854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
    Reddy JA; Xu LC; Parker N; Vetzel M; Leamon CP
    J Nucl Med; 2004 May; 45(5):857-66. PubMed ID: 15136637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
    Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
    J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
    Müller C; Schubiger PA; Schibli R
    Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary evaluation of a
    Song M; Guo Z; Gao M; Shi C; Xu D; You L; Wu X; Su X; Zhuang R; Pan W; Liu T; Zhang X
    Chem Biol Drug Des; 2017 May; 89(5):755-761. PubMed ID: 27910223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
    Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
    J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, characterization and evaluation of a new
    Das S; Sakhare N; Kumar D; Mathur A; Mirapurkar S; Sheela M; Mohanty B; Chaudhari P; Chakraborty S
    Bioorg Med Chem Lett; 2023 Apr; 86():129240. PubMed ID: 36931350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
    Ayala-López W; Xia W; Varghese B; Low PS
    J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.